Skip to main content
. 2023 Jun 28;24(13):10753. doi: 10.3390/ijms241310753

Table 1.

Parameter estimates from the final linear mixed-effects models for outcome.

Outcome
Model Term Grip Strength
(per Unit of Weight) g/g BW
Ketone Bodies (mmol/L)
Estimate (SE) p-Value Estimate p-Value
Intercept 3.04 (0.11) <0.001 0.487 (0.067) <0.001
Effect of KD vs. CD (without GEM, at day 30) −0.17 (0.11) 0.121 0.128 (0.08) 0.115
Effect of GEM vs. No GEM (with CD, at day 30) 0.07 (0.093) 0.436 −0.148 (0.094) 0.121
Effect of Time since intervention (in days)(with CD and no GEM) −0.02 (0.0039) <0.001 −0.002 (0.003) 0.402
Effect of baseline age (in days) −0.0042 (0.0036) 0.247 0.001 (0.002) 0.654
Effect of Male vs. Female −0.35 (0.085) <0.001 - -
Effect of baseline outcome 0.14 (0.073) 0.066 0.016 (0.196) 0.935
Interaction between KD and GEM - - 0.355 (0.124) 0.006
Interaction between KD and Time 0.021 (0.0053) <0.001 0.008 (0.004) 0.024
Interaction between GEM and Time - - 0.005 (0.004) 0.222
Interaction between KD, GEM, and Time - - −0.018 (0.005) 0.002

Note: Linear mixed-effects regression models were fitted for repeatedly measured post-treatment outcomes, which included fixed effects for diet, drug, time, and their 2-way and 3-way interactions (if significant), baseline age, sex, baseline outcome, and random intercepts for animal. Abbreviations: CD: control diet; KD: ketogenic diet; GEM: Gemcitabine.